human
cosaviru
novel
picornaviru
recent
identifi
fece
children
southern
asia
report
infect
human
cosaviru
patient
mediterranean
area
patient
adult
doubl
lung
transplant
recipi
chronic
diarrhea
associ
persist
infect
human
cosaviru
n
new
viru
detect
fecal
sampl
children
nonpolio
acut
flaccid
paralysi
genom
structur
new
viru
close
relat
famili
picornavirida
phylogenet
analysi
show
diverg
known
picornavirus
thu
new
genu
picornavirus
propos
human
cosaviru
common
stoolassoci
viru
hcosv
preval
hcosv
vari
accord
patient
age
geograph
area
exposur
enter
virus
gener
identifi
fecal
sampl
children
acut
flaccid
paralysi
pakistan
afghanistan
healthi
children
adult
patient
unit
kingdom
studi
kapoor
et
al
hcosv
strain
classifi
speci
b
e
hcosv
also
found
child
acut
diarrhea
australia
subsequ
detect
china
thailand
brazil
china
hospit
healthi
children
hcosv
posit
viru
strain
belong
speci
thailand
hcosv
detect
adult
patient
children
acut
diarrhea
brazil
percentag
hcovposit
symptomat
children
compar
report
china
howev
group
asymptomat
children
sampl
collect
differ
period
hcosv
detect
highli
diverg
percentag
vs
brazil
hcosv
also
detect
hivposit
adult
patient
acut
gastroenter
symptomat
hcosvposit
patient
coinfect
gastroenter
virus
kapusinszki
et
al
recent
conduct
phylogenet
analysi
viral
protein
vp
gene
reveal
greater
genet
variabl
hcosv
strain
propos
split
speci
speci
speci
e
speci
classifi
f
speci
report
case
hcosv
infect
immunocompromis
woman
northern
itali
result
retrospect
hcosv
test
store
fecal
sampl
hospit
patient
gastrointestin
sign
symptom
studi
perform
accord
guidelin
institut
review
board
fondazion
istituto
di
ricovero
e
cura
caratter
scientifico
policlinico
san
matteo
pavia
itali
use
biolog
specimen
scientif
purpos
keep
italian
law
articl
dlg
obtain
written
inform
consent
patient
white
woman
undergon
pulmonari
lobectomi
childhood
underw
bilater
lung
transplant
sever
chronic
respiratori
failur
caus
bilater
bronchiectasi
posttranspl
period
complic
bronchiol
obliteran
syndrom
stage
episod
acut
respiratori
distress
immunosuppress
regimen
includ
tacrolimu
level
ngml
lowdos
steroid
mgkgday
monthli
cours
extracorpor
photopheresi
initi
cours
lowdos
azythromycin
discontinu
lack
efficaci
januari
patient
respiratori
condit
worsen
hospit
cough
fever
abdomin
cramp
diarrhea
bowel
movementsday
liquid
bloodi
routin
fecal
examin
cultur
neg
common
gastrointestin
bacteria
mycobacteria
salmonella
shigella
campylobact
spp
parasit
protozoa
helminth
virus
astroviru
noroviru
rotaviru
adenoviru
patient
persist
gastrointestin
symptom
posit
fecal
calprotectin
result
colonoscopi
perform
reveal
inflam
cecal
mucosa
without
ulcer
lesion
histolog
examin
colon
biopsi
sampl
show
mild
chronic
interstiti
inflamm
includ
eosinophil
lymphoid
microaggreg
therefor
fecal
sampl
examin
less
common
gastroenter
viral
agentsrhinoviru
bocaviru
enteroviru
parechoviru
coronaviru
sapoviru
aichiviru
hcosvbi
use
convent
realtim
pcr
nest
revers
transcript
pcr
rtpcr
sampl
neg
gastrointestin
virus
search
except
hcosv
viru
detect
nest
rtpcr
target
untransl
region
utr
quantifi
basi
serial
log
dilut
extract
nucleic
acid
estim
presenc
rna
copi
ml
fecal
sampl
utr
amplicon
sequenc
use
abi
prism
dna
automat
sequenc
appli
biosystem
foster
citi
ca
usa
assembl
sequenc
softwar
version
gene
code
corpor
ann
arbor
mi
usa
compar
avail
hcosv
sequenc
blast
program
http
blastncbinlmnihgov
nucleotid
ident
hcosv
speci
speci
genbank
access
utr
suffici
discriminatori
type
sequenc
highli
variabl
region
encompass
gene
obtain
accord
publish
protocol
phylogenet
analysi
perform
maximumlikelihood
method
paramet
select
model
select
tool
mega
version
show
hcosv
sequenc
itali
cluster
speci
e
strain
found
australia
bolivia
recombin
de
strain
circul
nigeria
although
homolog
greatest
nt
aa
ident
strain
australia
genbank
access
figur
hypothesi
hcosv
strain
might
de
recombin
strain
exclud
recombin
breakpoint
gene
investig
defin
circul
hcosv
northern
itali
retrospect
test
store
fecal
sampl
hcosv
posit
use
nest
rtpcr
surprisingli
none
sampl
posit
hcosv
absenc
specif
therapi
patient
report
underw
parenter
rehydr
nutrit
supplement
gener
condit
improv
progress
bowel
movement
reduc
per
day
enabl
discharg
within
month
howev
gastrointestin
symptom
persist
fecal
sampl
collect
month
discharg
posit
hcosv
strain
high
titer
viru
rna
copiesml
fece
neg
virus
bacteria
parasit
report
identif
hcosv
mediterranean
area
infect
detect
patient
gastrointestin
symptom
hospit
test
period
uniqu
patient
prolong
immunosuppress
therapi
chronic
gastrointestin
symptom
persist
hcosvposit
fecal
sampl
persist
symptom
viru
addit
new
find
might
associ
patient
immun
impair
sourc
infect
determin
howev
patient
deni
domest
intern
travel
close
contact
person
return
travel
hcosv
infect
detect
patient
hospit
institut
period
hypothes
infect
acquir
patient
commun
hospit
genet
similar
e
strain
circul
south
america
australia
central
africa
suggest
local
acquisit
import
infect
howev
addit
evid
requir
exclud
potenti
autochthon
circul
hcosv
northern
itali
